Roham Parsa

@rohamparsa.bsky.social

Group Leader at Biohub New York. Adjunct Assistant Professor at The Rockefeller University. Immunologist with a passion for T cells! parsalab.org

I’m very fascinated about this study showing stem cell-like effector CD4 T cells that can become the classic T helper subsets. In tumors, Tregs suppress these cells, blocking Th1 seeding and anti-tumor effects! Jenkins lab also recently described a similar CD4 phenotype with different implications.

Differentiation fate of a stem-like CD4 T cell controls immunity to cancer - Nature

A population of tumour-specific PD1+TCF1+ CD4 T cells in tumour-draining lymph nodes is capable of self-renewal and differentiation into CD4 effector cells, thereby controlling CD8 T cell activity.

nature.com